VERAPAMIL VIATRIS LP 240 mg, film-coated tablet scored with extended release 90 tablets
Active ingredients: Verapamil hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored with extended release90 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VERAPAMIL VIATRIS LP 240 mg, comprimé pelliculé sécable à libération prolongée
- Pharmaceutical form
- comprimé pelliculé sécable à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 90 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 16 Aug 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69166273CIP73015683CIP133400930156834Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE VÉRAPAMILcomprimé | 240 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.